The LLSC Pediatric Blood Cancer Research Innovation Grant 2027, offered by the Leukemia & Lymphoma Society of Canada, supports research into childhood blood cancers, including rare subtypes.
The competition opens November 2, 2026, offering up to CAD $200,000 over two years. Its focus is foundational science that improves understanding of disease mechanisms and identifies potential therapeutic targets.
Eligibility and Application Requirements
- Open to Canadian researchers.
- Projects must focus on pediatric blood cancers.
- Research should advance foundational knowledge of disease mechanisms or therapeutic targets.
- Rare pediatric blood cancer subtypes are within scope.
- Applicants must submit a mandatory letter of intent.
- Full applications are accepted by invitation following LOI review.
- Both stages must be submitted through ProposalCentral.
Funding Details
- Maximum total: CAD $200,000.
- Annual maximum: CAD $100,000.
- Duration: Two years.
Deadline
- LOI: December 3, 2026, at 4:00 p.m. ET.
- Invitations: December 2026.
- Invited full application: February 10, 2027, at 4:00 p.m. ET.
- Award notification: Fall 2027.